相关实验视频
Updated: Jun 15, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.8K
评估在怀孕期间糖尿病的数字化管理系统的有效性和可接受性:观察性队列研究的协议
Byung Soo Kang1, Jin Yu2, Kyuho Kim3
1Department of Obstetrics and Gynecology, The Catholic University of Korea Seoul St Mary's Hospital, Seoul, Korea.
BMJ open
|June 12, 2025
概括
这项研究评估了MomStart,这是一个用于管理怀孕期间糖尿病的数字系统. 它旨在通过加强患者支持和数据记录来改善孕产妇和新生儿的结果.
科学领域:
- 产科和妇科 产科和妇科
- 内分泌学 在内分泌学.
- 数字健康数字健康
背景情况:
- 怀孕期间的糖尿病对母亲和婴儿构成重大风险,需要全面管理.
- 妊娠糖尿病 (GDM) 的全球流行率不断上升,需要高效和易于获得的医疗保健解决方案.
- 目前的GDM管理面临的挑战是由于频繁的医院访问和有限的专家可用性.
研究的目的:
- 评估数字化管理系统 (MomStart) 对糖尿病妇女怀孕结果的影响.
- 为了评估MomStart移动应用程序的可用性和用户满意度.
- 将怀孕结果与糖尿病妇女的历史数据进行比较.
主要方法:
- 在韩国招募100多名糖尿病孕妇参加初级研究.
- 将另外500名女性纳入补充可用性研究.
- 收集和分析有关新生儿和母亲结局,应用程序保留率和满意度的数据.
主要成果:
- 这项研究正在进行中,结果正在等待.
- MomStart应用程序促进了数据记录,教育内容交付和医疗保健提供者的沟通.
- 该研究协议已获得伦理批准,并以KCT0008483.3号注册.
结论:
- 像MomStart这样的数字健康解决方案有望改善怀孕期间糖尿病的管理.
- 需要进一步的研究,以充分阐明数字干预对母亲和新生儿结果的好处.
- 研究结果将通过国家会议和同行评审的医学期刊传播.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Diabetes: Management and Pharmacotherapy
245
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
245
Pathophysiology of Diabetes
908
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
908
Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Oral Hypoglycemic Agents: Biguanides and Glitazones
183
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
183
Diabetes: Symptoms, Diagnosis, and Complications
520
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
520

